BSE filing, NSE: AARTIDRUGS. Summary written from the filing by ALFA Finder's alert engine.
Aarti Drugs Ltd: key numbers
- Share price
- ₹507.35
- Market cap
- ₹4,631 Cr
- Revenue (annual)
- ₹2,565 Cr
- Net profit (annual)
- ₹194.9 Cr
- P/E (TTM)
- 20.2×Sector 43.7×
- Promoter holding
- 54.07%-0.36% QoQ
- FII holding
- 2.26%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Aarti Drugs Ltd
All →Aarti Drugs Business Update
Aarti Drugs disclosed that the US FDA inspected its subsidiary Pinnacle Life Science's Baddi plant on 2-6 November 2026 and issued three Form 483 observations. The company states there is no financial or operational impact.
Aarti Drugs Investor Presentation: Key Takeaways
Q2 FY27 consolidated revenue Rs 826.2 Cr (+27% YoY), EBITDA Rs 137.9 Cr (16.6% margin, +370 bps), PAT Rs 82.8 Cr (+83%). Specialty chemicals nearly doubled; formulations grew 58%.
Aarti Drugs Results Update
Aarti Drugs reports Q2 FY27 revenue of ₹828.8 Crore and PAT of ₹82.8 Crore, up 83% YoY. Results reflect record quarterly EBITDA and margin expansion.
Aarti Drugs Q2 FY27 Results: Net Profit ₹82.8 Cr, Up 83.2% YoY
Aarti Drugs Ltd reported revenue from operations of ₹826.2 Cr (+26.6% YoY) and net profit of ₹82.8 Cr (+83.2% YoY) for Q2 FY27.
- Key figure
- Net profit ₹82.8 Cr · +83.2% YoY
Aarti Drugs Board Meeting Date
Aarti Drugs Ltd intimated BSE and NSE of a board meeting on November 3, 2026, to consider audited financial results for the quarter and half year ended September 30, 2026. Trading window remains closed until 48 hours after results declaration.
Aarti Drugs Other Announcement
The company submitted its quarterly shareholding pattern as of September 30, 2026, in compliance with SEBI Listing Regulations.
Other other announcement announcements
All →Unicommerce eSolutions Other Announcement
Unicommerce cancelled its 18 November 2026 CLSA group investor meeting due to exigencies. The filing carries no financial or business event.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs reports the demise of Chairman Emeritus and Promoter Chandrakant Gogri today. He ceases to be classified as a Promoter under Regulation 31A(6)(c).
Valiant Organics Other Announcement
Valiant Organics reports the demise of Chairman Emeritus Chandrakant Gogri, a Promoter Group member. He has ceased to be a Promoter Group member under Regulation 31A(6)(c).
Aarti Industries Other Announcement
Aarti Industries announced the demise of promoter and Chairman Emeritus Chandrakant Gogri on November 15, 2026. He ceases to be a promoter under Regulation 31A(6)(c).
Valiant Laboratories Other Announcement
Valiant Laboratories disclosed the demise of promoter group member Chandrakant Gogri on November 15, 2026. He ceases to be promoter group under Regulation 31A(6)(c).
Ellenbarrie Industrial Gases Other Announcement
Ellenbarrie filed its IPO monitoring agency report for the quarter ended September 30, 2026. Proceeds were utilised as per the offer document, with no deviations.